Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung.

Oncotarget · 2016 · PMC5342490 · PMID 27626312

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients harboring tumors with NRG1 fusions also showed a trend towards shorter disease-free survival (DFS) compared with those without NRG1 fusion (Figure 6B ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.